Reaction
Urticaria Chronic reporting signals
As of the last recalculation, Urticaria Chronic appears in 546 FAERS reports alongside 6 co-occurring drug terms. The strongest observed disproportionality signal is OMALIZUMAB (PRR 54.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Omalizumab | 100 | 54.5 | 54.6 |
| Cetirizine Hydrochloride Allergy | 32 | 42.7 | 42.8 |
| Cetirizine Hydrochloride Tablets | 32 | 42.7 | 42.8 |
| Cetirizine | 66 | 36.7 | 36.8 |
| Doxepin | 9 | 34.4 | 34.4 |
| Cetiirizine | 35 | 33.6 | 33.6 |